Invesco Biotechnology & Genome ETF (PBE) Implied Volatility Current

Tracking PBE implied volatility helps you identify when options premiums on Invesco Biotechnology & Genome ETF are historically cheap or expensive, and where the best trades are hiding. Invesco Biotechnology & Genome ETF implied volatility reflects the market's expectation of future price movement: when PBE IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Invesco Biotechnology & Genome ETF's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PBE, tracking metrics like PBE IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PBE signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PBE implied volatility sits today versus where it has been. Our scanner ranks Invesco Biotechnology & Genome ETF implied volatility against its historical range, surfaces extremes in PBE IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Invesco Biotechnology & Genome ETF IV is rich or cheap — measure it, then act on it.